Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells

Tanya Leger, John Grist, Fulvio D'Acquisto, Anna K. Clark, Marzia Malcangio

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Abstract

Immune-neuronal interactions contribute to neuropathic pain. Thus, immune-competent cells such as microglia may provide targets for pain relief, as may infiltrating lymphocytes. We evaluated the nature of the lymphocyte response in the spinal cord in association with the maintenance of neuropathic allodynia. We assessed T cell contribution to pain processing by targeting these cells with Glatiramer acetate (GA) which when administered systemically reversed neuropathic allodynia, inhibited microglia response and increased IL-10 and IL-4 expressing T cells in neuropathic dorsal horns. These studies advance understanding of lymphocyte contribution to chronic pain and reveal a new mechanism of T cell intervention. (C) 2011 Elsevier B.V. All rights reserved.
Original languageEnglish
Pages (from-to)19 - 26
Number of pages8
JournalJournal of Neuroimmunology
Volume234
Issue number1-2
DOIs
Publication statusPublished - May 2011

Fingerprint

Dive into the research topics of 'Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells'. Together they form a unique fingerprint.

Cite this